Abiopharma

🔍 Murphy-Chutorian Douglas (Director)

Company: Semler Scientific, Inc. (SMLR)

Report Date: 2025-08-25

Detailed Transactions and Holdings:

• Acquired 60,000 shares of Common Stock at $2.56 per share (Direct)
  Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 60,000.00 | transaction_form_type: 4
• Sold 28,604 shares of Common Stock at $30.54 per share (Direct)
  Date: 2025-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,396.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 31,396 shares of Common Stock (Direct)
  Date: 2025-08-25 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
• Acquired 31,396 shares of Common Stock (Direct)
  Date: 2025-08-25 | Code: G | equity_swap_involved: 0 | shares_owned_after: 186,709.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3
• Sold 60,000 shares of Stock Option (right to buy) at $2.56 per share (Derivative)
  Date: 2025-08-25 | Code: M | Expires: 2025-12-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: The shares were sold by the reporting person to cover the exercise price and withholding taxes.
• F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $30.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
• F3: Shares are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities.
• F4: The shares underlying the option are fully vested and immediately exercisable.